2009
DOI: 10.1007/s00101-009-1626-9
|View full text |Cite
|
Sign up to set email alerts
|

Anti-inflammatory effects of pentoxifylline

Abstract: Initially introduced as a rheologic agent for use in intermittent claudication due to peripheral artery disease and in ischemic cerebrovascular disease, the methylxanthine derivative pentoxifylline (PTX) has been shown to possess several anti-inflammatory properties which make this drug an interesting immunomodulating adjunct for the management of patients undergoing cardiac surgery. As an unspecific phosphodiesterase inhibitor PTX ameliorates the inflammatory response following a septic stimulus and blunts or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 52 publications
0
1
0
Order By: Relevance
“…PTX exhibits potent anti-inflammatory effects [31, 32], directly inhibits TNFα, and reduces inflammation in multiple preclinical models [3335], chemotherapy-induced intestinal (CPT-11) and oral (5-FU) mucositis [36, 37]. In combination with daily fractionated irradiation, PTX had significant effects on TNFα and IL-1β, but no effect on the mutual downstream protein NF-κB.…”
Section: Discussionmentioning
confidence: 99%
“…PTX exhibits potent anti-inflammatory effects [31, 32], directly inhibits TNFα, and reduces inflammation in multiple preclinical models [3335], chemotherapy-induced intestinal (CPT-11) and oral (5-FU) mucositis [36, 37]. In combination with daily fractionated irradiation, PTX had significant effects on TNFα and IL-1β, but no effect on the mutual downstream protein NF-κB.…”
Section: Discussionmentioning
confidence: 99%